Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Schaper Benz & Wise Investment Counsel Inc. WI

Schaper Benz & Wise Investment Counsel Inc. WI lowered its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report) by 0.8% in the 3rd quarter, Holdings Channel.com reports. The fund owned 34,646 shares of the medical equipment provider’s stock after selling 274 shares during the quarter. Intuitive Surgical comprises approximately 1.4% of Schaper Benz & Wise Investment Counsel Inc. WI’s portfolio, making the stock its 29th largest holding. Schaper Benz & Wise Investment Counsel Inc. WI’s holdings in Intuitive Surgical were worth $17,021,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in the business. Cedrus LLC acquired a new stake in Intuitive Surgical in the 3rd quarter valued at $208,000. New Century Financial Group LLC grew its stake in shares of Intuitive Surgical by 23.7% in the third quarter. New Century Financial Group LLC now owns 699 shares of the medical equipment provider’s stock valued at $343,000 after buying an additional 134 shares in the last quarter. Resonant Capital Advisors LLC lifted its position in Intuitive Surgical by 8.5% during the 3rd quarter. Resonant Capital Advisors LLC now owns 1,526 shares of the medical equipment provider’s stock worth $750,000 after acquiring an additional 119 shares in the last quarter. Veracity Capital LLC boosted its holdings in Intuitive Surgical by 6.4% in the 3rd quarter. Veracity Capital LLC now owns 598 shares of the medical equipment provider’s stock worth $294,000 after acquiring an additional 36 shares during the period. Finally, McBroom & Associates LLC raised its stake in shares of Intuitive Surgical by 0.7% during the third quarter. McBroom & Associates LLC now owns 18,540 shares of the medical equipment provider’s stock valued at $9,108,000 after purchasing an additional 132 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $521.15 on Friday. Intuitive Surgical, Inc. has a 1 year low of $254.85 and a 1 year high of $523.34. The firm’s 50-day moving average is $483.85 and its 200-day moving average is $438.17. The company has a market cap of $184.85 billion, a P/E ratio of 94.07, a PEG ratio of 5.40 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRGGet Free Report) last released its quarterly earnings data on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share for the quarter, topping the consensus estimate of $1.54 by $0.24. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. The firm had revenue of $2.01 billion for the quarter, compared to analyst estimates of $1.97 billion. During the same quarter in the prior year, the business earned $1.18 earnings per share. Intuitive Surgical’s quarterly revenue was up 14.5% on a year-over-year basis. As a group, sell-side analysts predict that Intuitive Surgical, Inc. will post 5.22 earnings per share for the current year.

Insider Activity

In related news, insider Mark Brosius sold 2,115 shares of the firm’s stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $491.91, for a total value of $1,040,389.65. Following the sale, the insider now owns 295 shares of the company’s stock, valued at approximately $145,113.45. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other Intuitive Surgical news, Director Craig H. Barratt sold 1,400 shares of the company’s stock in a transaction dated Tuesday, July 23rd. The shares were sold at an average price of $458.13, for a total value of $641,382.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Mark Brosius sold 2,115 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $491.91, for a total value of $1,040,389.65. Following the sale, the insider now directly owns 295 shares in the company, valued at approximately $145,113.45. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 53,120 shares of company stock valued at $25,528,753. 0.90% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

ISRG has been the subject of several analyst reports. Evercore ISI restated a “cautious” rating on shares of Intuitive Surgical in a research note on Friday. Mizuho upped their price objective on shares of Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday. Royal Bank of Canada lifted their target price on Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a research report on Friday. Leerink Partners increased their price target on Intuitive Surgical from $489.00 to $502.00 in a report on Thursday. Finally, Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a report on Friday. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $513.74.

Read Our Latest Report on ISRG

Intuitive Surgical Company Profile

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Recommended Stories

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.